This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearce, R. J. Articles by Roper, C. Search for Related Content PubMed PubMed Citation Articles by Pearce, R. J. Articles by Roper, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2003, p. 1347-1354, Vol. 47, No. 4
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.4.1347-1354.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom,¹ Kilimanjaro Christian Medical Centre and,³ The Joint Malaria Programme (JMP) Moshi, Tanzania²

Received 24 September 2002/ Returned for modification 12 November 2002/ Accepted 28 January 2003

The antimalarial combination of sulfadoxine and pyrimethamine (SP) was introduced as first-line treatment for uncomplicated malaria in Tanzania during 2001 following 18 years of second-line use. The genetic determinants of in vitro resistance to the two drugs individually are shown to be point mutations at seven sites in the dihydrofolate reductase gene (dhfr) conferring resistance to pyrimethamine and five sites in the dihydropteroate synthase (dhps) gene conferring resistance to sulfadoxine. Different combinations of mutations within each gene confer differing degrees of insensitivity, but information about the frequency with which allelic haplotypes occur has been lacking because of the complicating effects of multiple infection. Here we used a novel high-throughput sequence-specific oligonucleotide probe-based approach to examine the present resistance status of three Plasmodium falciparum populations in northern Tanzania. By using surveys of asymptomatic infections and screening for the presence of all known point mutations in dhfr and dhps genes, we showed that just five dhfr and three dhps allelic haplotypes are present. High frequencies of both triple-mutant dhfr and double-mutant dhps mutant alleles were found in addition to significant interregional heterogeneity in allele frequency. In vivo studies have shown that the cooccurrence of three dhfr mutations and two dhps mutations in an infection prior to treatment is statistically predictive of treatment failure. We have combined data for both loci to determine the frequency of two-locus genotypes. The triple-dhfr/double-dhps genotype is present in all three regions with frequencies ranging between 30 and 63%, indicating that treatment failure rates are likely to be high.

This article has been cited by other articles:

• Zhang, G. Q., Guan, Y. Y., Sheng, H. H., Zheng, B., Wu, S., Xiao, H. S., Tang, L. H. (2008). Multiplex PCR and Oligonucleotide Microarray for Detection of Single-Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance. J. Clin. Microbiol. 46: 2167-2174 [Abstract] [Full Text]  
• Enevold, A., Lusingu, J. P., Mmbando, B., Alifrangis, M., Lemnge, M. M., Bygbjerg, I. C., Theander, T. G., Vestergaard, L. S. (2008). Reduced Risk of Uncomplicated Malaria Episodes in Children with Alpha+-Thalassemia in Northeastern Tanzania. Am J Trop Med Hyg 78: 714-720 [Abstract] [Full Text]  
• Vestergaard, L. S., Ringwald, P. (2007). Responding to the Challenge of Antimalarial Drug Resistance by Routine Monitoring to Update National Malaria Treatment Policies. Am J Trop Med Hyg 77: 153-159 [Abstract] [Full Text]  
• Humphreys, G. S., Merinopoulos, I., Ahmed, J., Whitty, C. J. M., Mutabingwa, T. K., Sutherland, C. J., Hallett, R. L. (2007). Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria. Antimicrob. Agents Chemother. 51: 991-997 [Abstract] [Full Text]  
• DIALLO, D. A., SUTHERLAND, C., NEBIE, I., KONATE, A. T., ORD, R., POTA, H., ROPER, C., ILBOUDO-SANOGO, E., GREENWOOD, B. M., COUSENS, S. N. (2007). SUSTAINED USE OF INSECTICIDE-TREATED CURTAINS IS NOT ASSOCIATED WITH GREATER CIRCULATION OF DRUG-RESISTANT MALARIA PARASITES, OR WITH HIGHER RISK OF TREATMENT FAILURE AMONG CHILDREN WITH UNCOMPLICATED MALARIA IN BURKINA FASO. Am J Trop Med Hyg 76: 237-244 [Abstract] [Full Text]  
• Conway, D. J. (2007). Molecular Epidemiology of Malaria. Clin. Microbiol. Rev. 20: 188-204 [Abstract] [Full Text]  
• LEMNGE, M., ALIFRANGIS, M., KAFUYE, M. Y., SEGEJA, M. D., GESASE, S., MINJA, D., MASSAGA, J. J., RONN, A. M., BYGBJERG, I. C. (2006). High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in muheza villages, northeastern Tanzania.. Am J Trop Med Hyg 75: 188-193 [Abstract] [Full Text]  
• Pearce, R., Malisa, A., Kachur, S. P., Barnes, K., Sharp, B., Roper, C. (2005). Reduced Variation Around Drug-Resistant dhfr Alleles in African Plasmodium falciparum. Mol Biol Evol 22: 1834-1844 [Abstract] [Full Text]  
• Reyburn, H., Mbatia, R., Drakeley, C., Bruce, J., Carneiro, I., Olomi, R., Cox, J., Nkya, W. M. M. M., Lemnge, M., Greenwood, B. M., Riley, E. M. (2005). Association of Transmission Intensity and Age With Clinical Manifestations and Case Fatality of Severe Plasmodium falciparum Malaria. JAMA 293: 1461-1470 [Abstract] [Full Text]  
• ALIFRANGIS, M., ENOSSE, S., PEARCE, R., DRAKELEY, C., ROPER, C., KHALIL, I. F., NKYA, W. M., RONN, A. M., THEANDER, T. G., BYGBJERG, I. C. (2005). A SIMPLE, HIGH-THROUGHPUT METHOD TO DETECT PLASMODIUM FALCIPARUM SINGLE NUCLEOTIDE POLYMORPHISMS IN THE DIHYDROFOLATE REDUCTASE, DIHYDROPTEROATE SYNTHASE, AND P. FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENES USING POLYMERASE CHAIN REACTION- AND ENZYME-LINKED IMMUNOSORBENT ASSAY-BASED TECHNOLOGY. Am J Trop Med Hyg 72: 155-162 [Abstract] [Full Text]  
• MUGITTU, K., NDEJEMBI, M., MALISA, A., LEMNGE, M., PREMJI, Z., MWITA, A., NKYA, W., KATARAIHYA, J., ABDULLA, S., BECK, H.-P., MSHINDA, H. (2004). THERAPEUTIC EFFICACY OF SULFADOXINE-PYRIMETHAMINE AND PREVALENCE OF RESISTANCE MARKERS IN TANZANIA PRIOR TO REVISION OF MALARIA TREATMENT POLICY: PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE MUTATIONS IN MONITORING IN VIVO RESISTANCE. Am J Trop Med Hyg 71: 696-702 [Abstract] [Full Text]  
• Ahmed, A., Bararia, D., Vinayak, S., Yameen, M., Biswas, S., Dev, V., Kumar, A., Ansari, M. A., Sharma, Y. D. (2004). Plasmodium falciparum Isolates in India Exhibit a Progressive Increase in Mutations Associated with Sulfadoxine-Pyrimethamine Resistance. Antimicrob. Agents Chemother. 48: 879-889 [Abstract] [Full Text]